Although splenic artery aneurysm is the commonest visceral and third most common intra abdominal aneurysm after aorta and iliac artery, aneurysm of splenic artery along with aneurysm of splenic vein and arteriovenous fistula is a rare entity. Most of them are <3 cm in diameter. Giant true splenic artery aneurysms are rare and very few lesions >10 cm have been reported. We report a case of 11 cm × 8 cm giant splenic vein aneurysm with splenic arteriovenous fistula as the 1st case of giant splenic venous aneurysm with arteriovenous fistula managed by endovascular treatment.
IntroductIon

S
plenic artery aneurysms are the most common splanchnic artery aneurysms, representing 60% of such lesions. 1) They are also the third most common intra-abdominal aneurysms after aorta and iliac arteries. 2) Reported risk of rupture varies from 3% to 9.6%, more significantly, 95% of splenic artery aneurysms discovered during pregnancy are ruptured, resulting in a disproportionately high maternal and fetal mortality rate. 3) Most of these aneurysms are small and saccular, 80% are located in mid or distal splenic artery. 4) On the other hand splenic arteriovenous fistulae are rare. They can result from spontaneous rupture of a splenic artery aneurysm into vein or may occur as a complication of splenectomy. The first published report was by Weigert in 1986. There are around 70 reports describing more than 75 cases, which have been published in world literature. 5) Giant aneurysms have rarely been reported.
We present a patient whose characteristic feature combined giant venous aneurysm associated with a hilar arteriovenous communication.
case report
A 37 years old woman who had 4 children the youngest is 4 months old; she was referred to our institution with diagnosis of splenic artery aneurysm associated with??Arteriovenous fistula, she gave history of 5 months vague left upper abdominal pain and tender swelling, on examination her pulse, blood pressure, and respiratory system were normal. Abdomen was lax with tender palpable left upper abdominal mass, a loud machinery murmur heard over left upper quadrant. Her hemoglobin, Platelet count, white blood cells and liver function tests were all within normal limit. She gave no history of abdominal trauma, no other gastrointestinal complaint. Triphasic CT abdomen showed two splenic venous aneurysmal dilatation close to splenic hilum measuring 2.2 cm × 1.7 cm and 9 cm × 8.9 cm subsequent to existing arteriovenous fistula, Portal vein was enlarged it measures 22.7 mm showing early enhancement at arterial phase denoting arterio-portal shunt, after diagnosis was confirm, a multidisciplinary discussion between vascular, hepatobiliary, and general surgery with interventional radiologist supported the surgical management which refused by patient and she preferred the second option of endovascular management.
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Under general anesthesia, 6 F access sheath was introduced through right common femoral artery, non selective abdominal angiogram was obtained, to identify the celiac trunk, splenic and hepatic arteries, with delayed images for portal vein, the digital subtraction angiography (DSA) images were obtained at rate of 2-3 frames/s. Non-ionic contrast agents (Ultravist R [iopromid] 370 IU per 100 mL, Schering-Germany) were administered using automatic injector.
Selective celiac trunk catheterization was performed followed by selective catheterization of splenic artery using C2 Cobra catheter (Johnson and Johnson, Cordis, USA) which placed at proximal part of splenic artery, selective splenic angiogram was done which showed, tortuous splenic artery with distal saccular aneurysmal dilatation, huge dilatation of splenic vein and early opacified dilated portal vein (Fig. 1) , repeated angiograms were done at different angles with 6frames/second aiming to assess the arteriovenous fistula. C2 cobra catheter was exchanged with 6 F Envoy guiding catheter (by Johnson and Johnson, Cordis, USA), through which 10 mmx4 cm balloon was advanced to proximal splenic artery, and temporary splenic artery occlusion was done by balloon inflation, angiogram was repeated through occlusive balloon and clearly delineated the wide neck arteriovenous fistula (Fig. 2) .
The existing tortuousity of splenic artery, as well as absence of distal landing zone omitted the possibility of using covered stent to occlude the existing fistula. Coil embolization of splenic aneurysm was decided however due to very high flow and wide neck arteriovenous fistula, there was high possibility of coil migration, splenic artery flow was again occluded by inflating balloon using 10 mm × 40 mm balloon at its proximal part, through which multiple (n = 8) 0.035 coils 12 mm × 14 cm (Fibered Platinum Coils, Boston Scientific Cork Ltd., Cork, Ireland) were deployed, at distal splenic artery distal to pancreatic branch (Fig. 3) , occlusion balloon kept inflated for 5 minutes for securing coils position, angiograms were done through occlusion balloon before and after deflation which confirm total occlusion of distal splenic artery and successful embolization.
Patient was shifted to word, 2 hours before angiogram patient received 1 gram of cefazolin which also repeated immediately after procedure; no significant complications were encountered apart from left sided minimal effusion which detected 2 days post procedure and required no medical interventional.
Follow up Doppler scanning was done twice and revealed patent portal vein with occluded distal part of splenic artery as well as splenic vein aneurysm, patients was discharged after 5 days. Two weeks later CT of abdomen showed complete occlusion of distal splenic artery, non opacified thrombosed aneurysm with multiple patches of splenic infarctions. Follow up CT after 1 year revealed again totally thrombosed distal splenic artery with remarkable improvement of previously detected splenic infarctions (Fig. 4) . 
dIscussIon
Splenic artery aneurysms when present are commonly related to branch origins. Those less than 2 cm in size can probably be ignored. Splenic arteriovenous fistulae are commonly due to spontaneous rupture of a pre-existing splenic artery aneurysm into splenic vein. They are considered either congenital or acquired in origin, and mostly occur in women of childbearing age with a history of multiparity. The majority of traumatic splenic arteriovenous fistulae occur during splenectomy. Post-traumatic arteriovenous fistulae usually follow blunt trauma, and usually occurs within one year of trauma, However, Yadav. R et al., describe case of huge splenic artery aneurysm with AVF measuring 18 cm × 15 cm, patient was nulliparous, had never been pregnant and she had no history of abdominal trauma. 6) Giant aneurysms of splenic artery (diameter ≥10 cm) are exceptional. Only 12 cases have been reported so far in English literature. 7) First reported by Beaussier in 1770.
The precise mechanism of its formation is unknown; however it has been associated with a number of conditions, most common with pregnancy and portal hypertension. Other conditions include systemic hypertension, atherosclerosis, medial fibro dysplasia, systemic infection, and various congenital diseases. 8) None of these known etiologic factors was present in our patient.
Giant splenic aneurysms are rarely asymptomatic, abdominal pulsatile mass and bruit is usually the presenting symptoms. Patients suffering from splenic arteriovenous fistulae are characterized by effect of portal hypertension. An evaluation of 31 cases described in literature showed that symptoms such as splenomegaly (around 55%) barometric portal hypotension (45%), esophageal varices (52%), gastrointestinal bleeding (45%), ascites (35%), and diarrhea (19%) were observed. The most frequently observed symptoms were machinery-type bruit over left flank. It has been also reported a lifetime risk of rupture of 2%-10% with an associated mortality of 25%. 9) These rates increase remarkably among pregnant women whereas the estimated risk of rupture can reach up to 50% with related maternal and fetal mortality of 70% and 75% respectively. 10) The rupture may take place either into gastrointestinal tract and peritoneal cavity or into splenic vein resulting in splenic arteriovenous fistula development.
It is well known that the nidus of AVMs is fundamentally a conglomeration of arteriovenous fistulae. 11) In 1993, Houdart et al., 12) classified intracranial AVMs into 3 types based on the morphology of the nidus: arteriovenous, arteriolovenous, or arteriolovenulous. In 2006 Cho SK, Do YS, et al. modified this classification into 4 types according to their angiographic morphologies. Type I (arteriovenous fistulae) referred to at most 3 separate arteries shunted to a single draining vein, which is compatible with our case. Type II (arteriolovenous fistulae) indicated multiple arterioles shunted into a single draining vein. Type III AVMs (arteriolovenulous fistulae) had multiple shunts between the arterioles and venules. In this type, if the fistula unit of the nidus was observed as a blush or fine striation on angiography, it was categorized as type IIIa for a non-dilated fistula; when the fistula unit of the nidus was observed as a complex vascular network, it was classified as type IIIb for a dilated fistula. 13) Although most reports have established diagnosis through abdominal arterial angiography, and selecting celiac axis which can elegantly demonstrate arteriovenous shunting, yet Ultrasound together with colored Doppler, Magnetic resonance and CT angiography also play important role as base line evaluation and for post management follow up.
Splenic artery aneurysms should be promptly treated in high risk patients with symptomatic or expanding aneurysms, women of childbearing age and also patients undergoing liver transplantation. 14) Traditionally surgical resection with or without splenectomy is employed in treatment of splenic artery aneurysms, 15) however, this patient carried a substantial risk owing to continuing variceal bleeding and high possibility of aneurysmal rupture during surgery. In addition, surgical approach of splenic arteriovenous fistulas presents often with technical difficulties because of distal site of the lesion, formation of adhesions and numerous portal collaterals.
Laparoscopic treatments of common splenic artery aneurysms have been described, but to our knowledge, have not yet been used for treatment of giant lesions. 16) Non-surgical endovascular treatment of giant splenic artery aneurysms have been recently described; particularly for patients at high risk operative repair or those with lesions difficult to treat surgically, stent grafts have been used for exclusion of visceral artery aneurysms. This technique allows preservation of a continuous arterial access to spleen. The main caveat with these endovascular techniques is that they may be impractical for long and extremely tortuous lesions, so a stent graft well not be considered as a feasible solution mostly due to hilar presence of splenic fistula and tortuousity of splenic artery. A thirty six percutaneous catheter embolization of giant aneurysms and even ruptured giant aneurysms with metal coils, balloons, and sponges has been reported with favorable results, 17) with potential complications include pain fever, embolism to other visceral arteries, abscess formation, arterial disruption, contrast nephrotoxicity, incomplete occlusion and re-canalization, despite these drawbacks, transcatheter embolization appears to have a lower incidence of serious complications compared with surgery, has a success rate of approximately 85%, and may even be considered as a first-line treatment in appropriate patients. 18) On the other hand it is less invasive, relatively low-risk, rapid procedure can be easily applied regardless location of vascular malformation and it does not necessitate splenectomy.
These advantages of trans-catheter arterial embolization over surgery support strongly its efficacy in treating safely patients with splenic artery aneurysm complicated with arteriovenous fistula. 15) conclusIon Endovascular techniques are efficient, of low risk and can be indicated in patients with splenic arteriovenous malformation with giant venous aneurysmal dilatation.
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